Literature DB >> 34525273

Cerebrospinal fluid neurogranin in Alzheimer's disease studies: are immunoassay results interchangeable?

Clément Aveneau1, Claire Hourregue1, Emmanuel Cognat1, Julien Dumurgier1, Hugo Vanderstichele2, Eugeen Vanmechelen2, Henrik Zetterberg3, Jacques Hugon1, Kaj Blennow3, Claire Paquet1, Elodie Bouaziz-Amar4.   

Abstract

Entities:  

Keywords:  Alzheimer’s disease; biomarker; cerebrospinal fluid; immunoassay; neurogranin

Mesh：

Substances：

Year:  2021        PMID： 34525273      PMCID： PMC9481247          DOI： 10.1515/cclm-2021-0505

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   8.490


× No keyword cloud information.
  10 in total

1.  Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Authors:  Erik Portelius; Henrik Zetterberg; Tobias Skillbäck; Ulrika Törnqvist; Ulf Andreasson; John Q Trojanowski; Michael W Weiner; Leslie M Shaw; Niklas Mattsson; Kaj Blennow
Journal:  Brain       Date:  2015-09-15       Impact factor: 13.501

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.

Authors:  Rawan Tarawneh; Gina D'Angelo; Dan Crimmins; Elizabeth Herries; Terry Griest; Anne M Fagan; Gregory J Zipfel; Jack H Ladenson; John C Morris; David M Holtzman
Journal:  JAMA Neurol       Date:  2016-05-01       Impact factor: 18.302

4.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

5.  Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

Authors:  Eline A J Willemse; Ann De Vos; Elizabeth M Herries; Ulf Andreasson; Sebastiaan Engelborghs; Wiesje M van der Flier; Philip Scheltens; Dan Crimmins; Jack H Ladenson; Eugeen Vanmechelen; Henrik Zetterberg; Anne M Fagan; Kaj Blennow; Maria Bjerke; Charlotte E Teunissen
Journal:  Clin Chem       Date:  2018-03-09       Impact factor: 8.327

6.  Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Authors:  Hlin Kvartsberg; Flora H Duits; Martin Ingelsson; Niels Andreasen; Annika Öhrfelt; Kerstin Andersson; Gunnar Brinkmalm; Lars Lannfelt; Lennart Minthon; Oskar Hansson; Ulf Andreasson; Charlotte E Teunissen; Philip Scheltens; Wiesje M Van der Flier; Henrik Zetterberg; Erik Portelius; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2014-12-19       Impact factor: 21.566

7.  Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease.

Authors:  Marion Tible; Åsa Sandelius; Kina Höglund; Ann Brinkmalm; Emmanuel Cognat; Julien Dumurgier; Henrik Zetterberg; Jacques Hugon; Claire Paquet; Kaj Blennow
Journal:  Neurology       Date:  2020-06-25       Impact factor: 9.910

8.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

9.  Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

Authors:  Maartje I Kester; Charlotte E Teunissen; Daniel L Crimmins; Elizabeth M Herries; Jack H Ladenson; Philip Scheltens; Wiesje M van der Flier; John C Morris; David M Holtzman; Anne M Fagan
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

10.  Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.

Authors:  Won Hwa Kim; Annie M Racine; Nagesh Adluru; Seong Jae Hwang; Kaj Blennow; Henrik Zetterberg; Cynthia M Carlsson; Sanjay Asthana; Rebecca L Koscik; Sterling C Johnson; Barbara B Bendlin; Vikas Singh
Journal:  Neuroimage Clin       Date:  2018-10-23       Impact factor: 4.881
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.